BPC-157
Also called BPC, BPC157, body protection compound
BPC-157 is a small, stable piece of a protein your own stomach makes, and it's earned a reputation as the go-to "repair" peptide.
The published research here is animal and laboratory work. The ranges below come from community-reported dosing and results — what people have settled on in practice, and what they report happening.
12,755 posts20 communities
of community reporting analysed for this compound. That is the part you cannot find anywhere else — the trial data below it, you could look up yourself.
- Gut health
- Recovery & injury
The quick answer
BPC-157 is a small, stable piece of a protein your own stomach makes, and it's earned a reputation as the go-to "repair" peptide. The idea is simple: it helps your body build new blood vessels and lay down healthy tissue right where it's needed - which is why people reach for it with stubborn tendon, ligament, and joint injuries, and for calming an irritated gut.
Most describe it as repairing rather than masking. Gut issues often ease within a week or two, while tendons and joints tend to turn the corner around the 2–4 week mark. It works best paired with rest and rehab, and fresh injuries respond faster than old ones. Side effects are usually nothing more than mild irritation at the injection site.
Why people use it
🦵 Heals tendons, joints and muscle faster; 🩹 Soothes the gut - reflux, IBS, NSAID damage; 🔥 Calms inflammation around injuries; 🏃 Gets you back to training sooner; 🛡️ Protects the stomach lining
What people report using
These are ranges other people have reported running. They are here so you can see what has actually been done — they are not medical advice and not a recommendation for you.
People report running this anywhere from 0.5mg to 1mg, every day.Where somebody sits in that range depends on what they are using it for and what they are starting from — the low end is a deliberate choice a lot of people make, not a half-hearted version of the high end.
Gut health
- How often
- Every day
- Route
- subcutaneous
- Where this comes from
- Animal and lab research
Reflux, NSAID irritation and IBD-type symptoms are the reported uses.
Recovery & injury
- How often
- Every day
- Route
- subcutaneous
- Where this comes from
- Animal and lab research
Torn rotator cuffs, tennis elbow, arthritis, torn biceps, bad ankles.
Recovery & injury
- How often
- Every day
- Route
- subcutaneous
- Where this comes from
- Animal and lab research
Used to hold onto a recovery, or for ongoing gut and joint niggles rather than a specific injury.
10mg vial + 2ml BAC water = 5mg/ml. 1mg = 20u (0.2ml). Daily.
Work out your own units on the reconstitution calculator — the most common serious mistake in this area is arithmetic, not chemistry.
What to expect, and when
- First thing people notice
- Days 3–7 (pain, gut)
- When it gets real
- Weeks 2–3 (recovery)
- Where it peaks
- Months 1–2 (structural repair)
- Patience needed
- Medium - tissue takes time
- Days 1–3Loading phase, little felt yet
Preclinical work suggests BPC-157 begins acting on repair pathways early - upregulating VEGFR2 and nitric-oxide signaling tied to new blood-vessel formation. At this stage most of the action is biochemical, not something you feel. Users commonly report nothing dramatic in the first couple of days. Consistency matters more than any single dose.
- Days 3–7Early pain relief and gut comfort
This is where users most often report the first noticeable shift - reduced ache at an injury site or calmer digestion. Animal studies describe both analgesic and gut-protective effects, and reviews note gut comfort tends to respond before structural tissue does. Regard early relief as a signal the process is underway, not as full repair. Human data is still limited.
- Weeks 2–3Recovery pace picks up
Preclinical models show increased fibroblast activity and earlier collagen organization by this window. Users often report that a nagging area tolerates daily use better and recovers faster between sessions. Research suggests the effect is on the repair environment - angiogenesis and cell migration - rather than an instant fix. Progress here is gradual and easy to underrate day to day.
- Weeks 4–6Collagen remodeling underway
Rat tendon and ligament studies describe improved collagen remodeling and biomechanical properties in this range. In a research context this is when the underlying tissue quality - not just symptoms - is thought to be changing. Users frequently report the most convincing functional gains around now. Because tissue turnover is slow, patience is the theme.
- Months 1–2Structural repair peak
Preclinical evidence points to the fullest structural remodeling accruing over one to two months of consistent exposure. This is the window researchers associate with meaningful tissue-level change rather than early symptom relief. Individual response varies widely and human clinical evidence remains preliminary. Judge the compound over this whole arc, not the first week.
Most evidence is from animal studies; human data is limited to small pilots and BPC-157 is not an approved drug - regard all of this as research context, not medical guidance.
Side effects, and what people do about them
Most people find this one of the easiest to get on with. A little nausea, a brief head-rush, or some tenderness at the injection site is about all anyone usually notices, and it tends to settle quickly. As with any newer peptide, it's smart to check with your doctor first if you have any ongoing health conditions - otherwise most people use it very comfortably.
Go deeper
Open these only if you want them.
How it actually works
Fifteen-amino-acid fragment of a protein found in gastric juice. No single receptor has been identified for it, which is worth saying plainly rather than papering over. The best-supported mechanism is upregulation of VEGFR2 signalling and modulation of the nitric-oxide pathway, which together drive new blood-vessel formation and fibroblast migration into damaged tissue. There is also evidence it increases growth-hormone receptor expression in tendon fibroblasts, which is a plausible route for the tendon reports specifically.
Nearly all of this is animal work. For stacking, the point is that it acts on the blood supply and signalling side of repair, while TB-500 acts on the cytoskeleton and cell migration side - different halves of the same problem, which is why they are so often run together and why that pairing is not simply doubling up.
What people report, in full
BPC-157 is probably the most-used peptide in the recovery and rehab crowd, and the feedback is largely positive. Most people say soft-tissue and pain relief kicks in within a week or two, mobility improves around weeks two to four, and deeper structural healing takes four to eight weeks - though how fast really depends on the injury. Roughly seven or eight out of ten notice a real difference by week four; the rest report little, usually chalked up to being a non-responder or expecting too much too soon.
A few tips come up again and again: people often pair an injury-site injection with a general dose, rotate their injection spots, and run it in four-to-eight-week cycles for chronic issues. And notably, pushing the dose past 1 mg doesn't seem to heal any faster than the usual 0.25–0.5 mg.
Worth knowing
This is the normal state of this category and it is not a black mark. It usually means nobody could patent the molecule tightly enough to fund a trial. It is not the same as having been tested and failed.
Sources and review
Most of what is useful about these compounds comes from people who have used them, not from trials. These are published analyses of what communities reported. We did not read the posts ourselves and we do not claim to.
12,755 posts20 communities
Reports from 2023-01-01 to 2024-05-18
Rosenberg AE, et al. Injuries, Injections, and Internet Forums: A Qualitative Study of Reddit User Perspectives on Peptide Therapy After Orthopaedic Surgery. Sports Health 2026;18(4):901-910.
Qualitative coding. No dose distributions reported.
Cerovecki T, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res 2010. PMID 20225319.Rat ligament injury model.
Sikiric P, et al. Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats — A Review. Pharmaceuticals 2024. PMID 39204186.Review of rat gastrointestinal studies.
These references were located by literature search and recorded as the primary sources behind this record. The publishers block automated retrieval, so they are pointers to the right papers rather than quotations we have checked line by line. They are replaced as we read them properly.
Last reviewed 2026-09-06.
People also look at
Still not sure?
Ask it the way you would ask a person. Follow-up questions are the point — it remembers what you already said.
Ask about BPC-157